Royal Melbourne Hospital
Royal Melbourne Hospital
Melbourne, Australia5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, in situ carcinoma, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 3 | 2026-07-10 | NCT04452591 | |
| Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Buruli ulcer disease, Infections, Mycobacterium Infections, Nontuberculous, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, skin disorder, ulcer disease | Recruiting | Phase 2 | 2026-06-30 | NCT06481163 | |
| Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 / Phase 3 | 2026-05-18 | NCT05892510 | |
| Pomalidomide as an Immune-enhancing Agent for the Control of HIV | HIV-1 Infection | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-07 | NCT06660498 | |
| Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery | Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease | Recruiting | Not applicable | 2024-11-21 | NCT04754022 |